Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516199 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Handbook of Therapeutic Antibodies: Technologies, Emerging Developments and Approved Therapeutics

John Wiley and Sons Ltd, July 2010, Pages: 1,250


  Description  
   Table of Contents   
   Author   
    
    
     
  Enquire before Buying   
  Send to a Friend   

Antibodies are an essential part of the immune system in vertebrates. Their generation involves a random mutation and rearrangement process and they can be in principle directed against any biological compound. In the last years biotechnological processes have been developed allowing for the selection of any antibody with a specific target and the subsequent large scale production of this antibody.

This most comprehensive reference source for the development, production and therapeutic application of antibodies is now available as a paperback edition. It includes general chapters presenting established technologies and clinical applications, chapters on emerging technologies, new therapeutic concepts, and clinical studies and detailed and specific information about currently approved therapeutic antibodies, including clinical data.

This is a must-have resource for academic researchers and decision makers in the industry, as well as healthcare professionals in the clinic.



Customers who bought this item also bought

Opportunities for Monoclonal Antibodies: Where Companies Are Spending Their Antibody Dollars

Therapeutic Monoclonal Antibodies: From Bench to Clinic

Drug Delivery in Cancer - Technologies, Markets and Companies

Personalized Medicine - Scientific and Commercial Aspects

Novel Antibodies & Therapeutic Proteins: Technological Challenges & Future Prospects

Breast Cancer Vaccines and Therapeutic Antibodies: Pipeline - 2011

Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Targets for Market Success

Next Generation Protein Engineering and Drug Design: Strategies to boost efficacy and improve drug delivery

Biosimilars (2009 - 2014)

Preclinical Development of Monoclonal Antibodies and Related Biologicals: Emerging Technologies and New Therapeutic Candidates



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds